Credit Suisse Downgrades Alexion Pharmaceuticals (ALXN) to Neutral
Tweet Send to a Friend
Credit Suisse analyst Martin Auster downgraded Alexion Pharmaceuticals (NASDAQ: ALXN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
